首页> 外国专利> Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections

Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections

机译:逆转录病毒ENV蛋白的子区域,编码该序列的DNA序列以及用于诊断,预防或治疗逆转录病毒感染的成分

摘要

In order to reduce the opportunities of HIV to evade vaccine induced immunity, the developement of subunit vaccines must concentrate on those epitopes which are major targets of the immune system. The most dominant neutralization site on the gp120 resides within the third variable domain V3 of the molecule. This epitope was first predicted from our group as the only hypervariable antigenic region without consensus sequence for N-glycosylation and discussed according to its immunological importance. To overcome highly typspecific V3 mediated neutralization described by other laboratories we designed, based on a comparison of V3 sequences derived from different independent virus isolates, a 36 amino acid gp120/V3 consensus peptide. This peptide was tested for its immunological reactivity using independent sera of HIV positive individuals and typespecific anti-V3-antisera. After conversion into DNA this sequence will be an important component of newly designed subunit vaccines.
机译:为了减少HIV逃避疫苗诱导的免疫的机会,亚单位疫苗的开发必须集中在那些作为免疫系统主要靶标的表位上。 gp120上最主要的中和位点位于分子的第三个可变域V3内。该表位首先从我们的组中预测为唯一的没有N-糖基化共有序列的高变抗原区,并根据其免疫学重要性进行了讨论。为了克服其他实验室描述的高度典型的V3介导的中和作用,我们基于对来自不同独立病毒分离株的V3序列的比较,设计了一个36个氨基酸的gp120 / V3共有肽。使用HIV阳性个体的独立血清和类型特异性抗V3抗血清测试了该肽的免疫反应性。转化为DNA后,该序列将成为新设计的亚单位疫苗的重要组成部分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号